These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 9449570)
1. On the use of ion-pair chromatography to elucidate doxorubicin release mechanism from polyalkylcyanoacrylate nanoparticles at the cellular level. Pepin X; Attali L; Domrault C; Gallet S; Metreau JM; Reault Y; Cardot PJ; Imalalen M; Dubernet C; Soma E; Couvreur P J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):181-91. PubMed ID: 9449570 [TBL] [Abstract][Full Text] [Related]
2. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. de Verdière AC; Dubernet C; Némati F; Soma E; Appel M; Ferté J; Bernard S; Puisieux F; Couvreur P Br J Cancer; 1997; 76(2):198-205. PubMed ID: 9231919 [TBL] [Abstract][Full Text] [Related]
3. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Soma CE; Dubernet C; Bentolila D; Benita S; Couvreur P Biomaterials; 2000 Jan; 21(1):1-7. PubMed ID: 10619673 [TBL] [Abstract][Full Text] [Related]
4. A computationally derived structural model of doxorubicin interacting with oligomeric polyalkylcyanoacrylate in nanoparticles. Poupaert JH; Couvreur P J Control Release; 2003 Sep; 92(1-2):19-26. PubMed ID: 14499182 [TBL] [Abstract][Full Text] [Related]
5. Influence of perfluorinated carboxylic acids on ion-pair reversed-phase high-performance liquid chromatographic separation of betacyanins and 17-decarboxy-betacyanins. Wybraniec S; Mizrahi Y J Chromatogr A; 2004 Mar; 1029(1-2):97-101. PubMed ID: 15032354 [TBL] [Abstract][Full Text] [Related]
6. Design of pH-responsive nanoparticles of terpolymer of poly(methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin. Shalviri A; Chan HK; Raval G; Abdekhodaie MJ; Liu Q; Heerklotz H; Wu XY Colloids Surf B Biointerfaces; 2013 Jan; 101():405-13. PubMed ID: 23010048 [TBL] [Abstract][Full Text] [Related]
7. [Ion pair-HPLC of some aromatic amino- and hydroxycarboxylic acids]. Jira T; Beyrich T; Reinhardt K Pharmazie; 1988 Jun; 43(6):418-21. PubMed ID: 3212029 [TBL] [Abstract][Full Text] [Related]
8. [Use of cyclodextrins in the formulation of polyalkylcyanoacrylate nanoparticles charged with different active ingredients]. Duchêne D; Ponchel G; Boudad H; da Silveira AM Ann Pharm Fr; 2001 Nov; 59(6):384-91. PubMed ID: 11924510 [TBL] [Abstract][Full Text] [Related]
9. Doxorubicin loading and eluting characteristics of bioresorbable hydrogel microspheres: in vitro study. Weng L; Le HC; Lin J; Golzarian J Int J Pharm; 2011 May; 409(1-2):185-93. PubMed ID: 21382461 [TBL] [Abstract][Full Text] [Related]
10. [Study on separation of epirubicin and doxorubicin isomers by displacement chromatography]. Qi Y; Chu X; Huang J Se Pu; 2004 Mar; 22(2):106-10. PubMed ID: 15712863 [TBL] [Abstract][Full Text] [Related]
11. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery. Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840 [TBL] [Abstract][Full Text] [Related]
12. Elution characteristics of doxorubicin-loaded microspheres differ by drug-loading method and microsphere size. Kos S; Wasan E; Weir G; Reb P; Cornell C; Ford JA; Liu DM J Vasc Interv Radiol; 2011 Mar; 22(3):361-8. PubMed ID: 21353988 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189 [TBL] [Abstract][Full Text] [Related]
14. Retention of ionisable compounds on high-performance liquid chromatography. XV. Estimation of the pH variation of aqueous buffers with the change of the acetonitrile fraction of the mobile phase. Subirats X; Bosch E; Rosés M J Chromatogr A; 2004 Dec; 1059(1-2):33-42. PubMed ID: 15628122 [TBL] [Abstract][Full Text] [Related]
15. Stability of doxorubicin combined with Radioselectan, a contrast agent, for chemoembolization. Chiadmi F; Daroso J; Schlatter J; Cisternino S; Ratiney R; Fontan JE J Clin Pharm Ther; 2005 Jun; 30(3):255-8. PubMed ID: 15896243 [TBL] [Abstract][Full Text] [Related]
16. Reversed-phase high-performance liquid chromatography of amphoteric beta-lactam antibiotics: effects of columns, ion-pairing reagents and mobile phase pH on their retention times. Huang HS; Wu JR; Chen ML J Chromatogr; 1991 Mar; 564(1):195-203. PubMed ID: 1860913 [TBL] [Abstract][Full Text] [Related]
17. Prediction of the chromatographic retention of acid-base compounds in pH buffered methanol-water mobile phases in gradient mode by a simplified model. Andrés A; Rosés M; Bosch E J Chromatogr A; 2015 Mar; 1385():42-8. PubMed ID: 25666497 [TBL] [Abstract][Full Text] [Related]
18. Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies. Zhang X; Sun X; Li J; Zhang X; Gong T; Zhang Z Pharmazie; 2011 Jul; 66(7):496-505. PubMed ID: 21812324 [TBL] [Abstract][Full Text] [Related]
19. An intramolecular cyclization reaction is responsible for the in vivo inefficacy and apparent pH insensitive hydrolysis kinetics of hydrazone carboxylate derivatives of doxorubicin. Lee CC; Cramer AT; Szoka FC; Fréchet JM Bioconjug Chem; 2006; 17(5):1364-8. PubMed ID: 16984149 [TBL] [Abstract][Full Text] [Related]
20. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin. Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]